gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and technetium tc-99m tetrofosmin

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with technetium tc-99m tetrofosmin in 2 studies

Compound Research Comparison

Studies (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)	Trials (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)	Recent Studies (post-2010) (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)	Studies (technetium tc-99m tetrofosmin)	Trials (technetium tc-99m tetrofosmin)	Recent Studies (post-2010) (technetium tc-99m tetrofosmin)
638	31	243	1,205	216	192

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arheden, H; Carlsson, M; Hedström, E; Heiberg, E; Jovinge, S; Ubachs, JF	1
Friedrich, MG	1

Other Studies

2 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and technetium tc-99m tetrofosmin

Article	Year
Myocardium at risk after acute infarction in humans on cardiac magnetic resonance: quantitative assessment during follow-up and validation with single-photon emission computed tomography. JACC. Cardiovascular imaging, 2009, Volume: 2, Issue:5 Topics: Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Female; Follow-Up Studies; Heart Ventricles; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardium; Organometallic Compounds; Organophosphorus Compounds; Organotechnetium Compounds; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Time Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome	2009
A closer look on the battlefield: the salvaged area at risk as an outcome marker for myocardial reperfusion. JACC. Cardiovascular imaging, 2009, Volume: 2, Issue:5 Topics: Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Heart Ventricles; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Myocardial Infarction; Myocardial Ischemia; Myocardium; Organometallic Compounds; Organophosphorus Compounds; Organotechnetium Compounds; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Time Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome	2009

Article

Year

Myocardium at risk after acute infarction in humans on cardiac magnetic resonance: quantitative assessment during follow-up and validation with single-photon emission computed tomography.

JACC. Cardiovascular imaging, 2009, Volume: 2, Issue:5

Topics: Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Female; Follow-Up Studies; Heart Ventricles; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardium; Organometallic Compounds; Organophosphorus Compounds; Organotechnetium Compounds; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Time Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome

2009

A closer look on the battlefield: the salvaged area at risk as an outcome marker for myocardial reperfusion.

JACC. Cardiovascular imaging, 2009, Volume: 2, Issue:5

Topics: Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Heart Ventricles; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Myocardial Infarction; Myocardial Ischemia; Myocardium; Organometallic Compounds; Organophosphorus Compounds; Organotechnetium Compounds; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Time Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome

2009